What are the typical doses of methimazole, radioactive iodine, beta-blockers (such as propranolol), and propylthiouracil for managing hyperthyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Typical Doses of Medications for Managing Hyperthyroidism

For adults with hyperthyroidism, methimazole should be initiated at 15 mg daily for mild disease, 30-40 mg daily for moderate disease, and 60 mg daily for severe disease, divided into three doses at 8-hour intervals. 1

Methimazole (MMI) Dosing

Adult Dosing

  • Initial dosing:
    • Mild hyperthyroidism: 15 mg daily
    • Moderate hyperthyroidism: 30-40 mg daily
    • Severe hyperthyroidism: 60 mg daily
    • Typically divided into 3 doses at 8-hour intervals 1
  • Maintenance dosing: 5-15 mg daily 1
  • Single daily dosing option: 15 mg once daily has been shown effective for mild to moderate disease, with 30 mg once daily more suitable for severe cases 2, 3

Pediatric Dosing

  • Initial dose: 0.4 mg/kg/day divided into 3 doses at 8-hour intervals
  • Maintenance dose: Approximately half of the initial dose 1

Propylthiouracil (PTU) Dosing

Adult Dosing

  • Initial dose: 300 mg daily
  • Severe hyperthyroidism or large goiters: 400 mg daily initially
  • Exceptional cases: 600-900 mg daily initially
  • Maintenance dose: 100-150 mg daily
  • Typically divided into 3 equal doses at 8-hour intervals 4

Pediatric Dosing

  • Generally not recommended except in rare instances
  • For children ≥6 years: 50 mg daily with careful upward titration based on clinical response and thyroid function tests
  • Caution: Severe liver injury has been reported with doses as low as 50 mg/day, but most cases occurred with doses ≥300 mg/day 4

Beta-Blockers (e.g., Propranolol)

While specific dosing information for beta-blockers in hyperthyroidism was not provided in the evidence, beta-blockers are mentioned as medications that can impair T4 to T3 conversion 5. Based on general medical knowledge:

  • Propranolol:
    • Typical starting dose: 10-40 mg 3-4 times daily
    • Dose can be adjusted based on heart rate control
    • Target heart rate typically <90 beats per minute

Radioactive Iodine

Specific dosing information for radioactive iodine was not provided in the evidence.

Clinical Considerations and Comparative Efficacy

  • MMI vs. PTU effectiveness: MMI is more effective than PTU at equivalent doses. A single daily dose of 15 mg MMI was shown to be more effective than 150 mg PTU in inducing euthyroidism in Graves' disease 6

  • MMI dosing for severe cases: In patients with severe hyperthyroidism (FT4 ≥7 ng/dl), MMI 30 mg/day normalized free T4 more effectively than PTU 300 mg/day or MMI 15 mg/day 2

  • Side effect profile: PTU has higher rates of adverse effects, especially mild hepatotoxicity, compared to MMI. MMI 15 mg/day has significantly lower adverse effects than MMI 30 mg/day 2

  • Duration of therapy: Long-term methimazole therapy (60-120 months) has been shown to result in higher remission rates (85%) compared to conventional 18-24 month courses (47%) 7

Important Caveats

  • PTU is generally not recommended as first-line therapy due to higher risk of hepatotoxicity, except in specific situations (first trimester of pregnancy, thyroid storm)
  • Elderly patients may require lower doses due to increased risk of adverse effects 4
  • Monitor thyroid function tests (TSH, free T4) regularly to adjust dosing
  • Be aware that beta-blockers can impair T4 to T3 conversion 5
  • Always check for medication interactions and adjust doses accordingly

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.